Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies
Hemasphere
.
2024 Jan 28;8(1):e37.
doi: 10.1002/hem3.37.
eCollection 2024 Jan.
Author
Roger E G Schutgens
1
Affiliation
1
Center of Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Centre Utrecht University Utrecht Utrecht The Netherlands.
PMID:
38434531
PMCID:
PMC10878177
DOI:
10.1002/hem3.37
No abstract available